Literature DB >> 16919002

Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Ho-Ki Shim1, Julie A Musson, Helen M Harper, Hesta V McNeill, Nicola Walker, Helen Flick-Smith, Alexei von Delwig, E Diane Williamson, John H Robinson.   

Abstract

We mapped mouse CD4 T-cell epitopes located in three structurally distinct regions of the V antigen of Yersinia pestis. T-cell hybridomas specific for epitopes from each region were generated to study the mechanisms of processing and presentation of V antigen by bone-marrow-derived macrophages. All three epitopes required uptake and/or processing from V antigen as well as presentation to T cells by newly synthesized major histocompatibility complex (MHC) class II molecules over a time period of 3-4 hr. Sensitivity to inhibitors showed a dependence on low pH and cysteine, serine and metalloproteinase, but not aspartic proteinase, activity. The data indicate that immunodominant epitopes from all three structural regions of V antigen were presented preferentially by the classical MHC class II-restricted presentation pathway. The requirement for processing by the co-ordinated activity of several enzyme families is consistent with the buried location of the epitopes in each region of V antigen. Understanding the structure-function relationship of multiple immunodominant epitopes of candidate subunit vaccines is necessary to inform choice of adjuvants for vaccine delivery. In the case of V antigen, adjuvants designed to target it to lysosomes are likely to induce optimal responses to multiple protective T-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919002      PMCID: PMC1819574          DOI: 10.1111/j.1365-2567.2006.02447.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  54 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

2.  Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis.

Authors:  Julie A Musson; Nicola Walker; Helen Flick-Smith; E Diane Williamson; John H Robinson
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

Review 3.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

4.  Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Authors:  Lélia Delamarre; Margit Pack; Henry Chang; Ira Mellman; E Sergio Trombetta
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

Review 5.  Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.

Authors:  Ping Li; Josetta L Gregg; Nan Wang; Delu Zhou; Patrick O'Donnell; Janice S Blum; Victoria L Crotzer
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

6.  Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.

Authors:  Timo Burster; Alexander Beck; Eva Tolosa; Petra Schnorrer; Robert Weissert; Michael Reich; Marianne Kraus; Hubert Kalbacher; Hans-Ulrich Häring; Ekkehard Weber; Herman Overkleeft; Christoph Driessen
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.

Authors:  M Svensson; B Stockinger; M J Wick
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Authors:  J K Pullen; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Authors:  V L Motin; R Nakajima; G B Smirnov; R R Brubaker
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Authors:  S E Leary; E D Williamson; K F Griffin; P Russell; S M Eley; R W Titball
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  13 in total

1.  Amino acid and structural variability of Yersinia pestis LcrV protein.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Evgeniy A Panfertsev; Tat'yana E Svetoch; Pavel Kh Kopylov; Brent W Segelke; Adam Zemla; Maxim V Telepnev; Vladimir L Motin
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

2.  Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Authors:  Julie A Musson; Rebecca Ingram; Guillaume Durand; Stephanie Ascough; Emma L Waters; M Gillian Hartley; Timothy Robson; Bernard Maillere; E Diane Williamson; Shiranee Sriskandan; Daniel Altmann; John H Robinson
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

Review 3.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

4.  Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.

Authors:  Claire A Cornelius; Lauriane E Quenee; Katie A Overheim; Frederick Koster; Trevor L Brasel; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

5.  Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.

Authors:  Anasuya Chattopadhyay; Steven Park; Guillaume Delmas; Rema Suresh; Svetlana Senina; David S Perlin; John K Rose
Journal:  Vaccine       Date:  2008-10-01       Impact factor: 3.641

Review 6.  Immune defense against pneumonic plague.

Authors:  Stephen T Smiley
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

7.  Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.

Authors:  Yoonkyung Do; Chae Gyu Park; Young-Sun Kang; Sung Ho Park; Rebecca M Lynch; Haekyung Lee; Bradford S Powell; Ralph M Steinman
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

8.  Intramolecular polyspecificity in CD4 T-cell recognition of Ad-restricted epitopes of proteoglycan aggrecan.

Authors:  Jane Falconer; Katie Lowes; Anna L Furmanski; Julian Dyson; Wan Fai Ng; John H Robinson
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

9.  The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.

Authors:  E D Williamson
Journal:  Adv Prev Med       Date:  2011-09-29

10.  Contrasted patterns of selection on MHC-linked microsatellites in natural populations of the Malagasy plague reservoir.

Authors:  Charlotte Tollenaere; Svilena Ivanova; Jean-Marc Duplantier; Anne Loiseau; Lila Rahalison; Soanandrasana Rahelinirina; Carine Brouat
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.